Thomas Strack, MD, Named CMO at Faeth Therapeutics

Faeth Therapeutics, a healthcare company developing machine learning-driven precision nutrition solutions and therapeutic regimens to treat cancer, announced the appointment of Endocrine Society member Thomas Strack, MD, as chief medical officer.

Strack brings more than 29 years of biopharmaceutical industry and has led all phases of clinical development. Strack previously served as senior vice president, Clinical Development, at Molecular Templates, a publicly traded biopharmaceutical company where he was responsible for first-in-human trials in patients with solid and hematological tumors. He was also vice president, Clinical Development, at Progenics, and an executive at Asubio where was responsible for first-in-human trials targeting CNS diseases. Strack also held executive positions at Takeda, Pfizer, and Eli Lilly and Company.

Strack earned his medical doctorate from the University in Mainz, Germany, where he completed his internal medicine and endocrinology residencies, with additional postdoctoral research at the Hospital for Sick Children in Toronto, Canada. He has authored numerous scientific and clinical publications.

You may also like

  • Hammer Wins Inaugural Endocrine Images Art Competition

    Gary Hammer, MD, PhD, Millie Schembechler professor of Adrenal Cancer at the University of Michigan in Ann Arbor, Mich., won the Endocrine Society’s Endocrine Images Art Competition, a contest celebrating the beauty of endocrine science. Entries were judged based on aesthetic value and significance to endocrine research. Hammer’s image of the adrenal gland took the top…

  • Endocrine Society’s Insulin 2121 Event Kickstarts Diabetes Awareness Month

    Throughout 2021, the Endocrine Society has focused on insulin’s past and present. The Society’s Insulin 2121 event highlights insulin’s future. Robots, drones, and artificial intelligence are just a few of the innovative topics being discussed. While the event is pre-recorded, our speakers will be live and available to answer your questions in real time during the Q&A portion.   More information on the…

Find more in